Brian I. Knapp
University of Rochester(US)
Publications by Year
Research Areas
Neuropeptides and Animal Physiology, Receptor Mechanisms and Signaling, Pharmacological Receptor Mechanisms and Effects, Chemical Synthesis and Analysis, Hydrology and Watershed Management Studies
Most-Cited Works
- → Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease(2012)114 cited
- → Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors(2003)78 cited
- → In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder(2018)62 cited
- → Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors(2007)61 cited
- → Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling(2010)57 cited
- → Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2–dependent activation of type II protein kinase A(2006)48 cited
- → Synthesis and Preliminary In vitro Investigation of Bivalent Ligands Containing Homo- and Heterodimeric Pharmacophores at μ, δ, and κ Opioid Receptors(2005)46 cited
- → Evolution of the Bifunctional Lead μ Agonist/δ Antagonist Containing the 2′,6′-Dimethyl-l-tyrosine−1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid (Dmt−Tic) Opioid Pharmacophore(2009)44 cited
- → Glycosylation Improves the Central Effects of DAMGO(2007)44 cited
- → 10-Ketomorphinan and 3-Substituted-3-desoxymorphinan Analogues as Mixed κ and μ Opioid Ligands: Synthesis and Biological Evaluation of Their Binding Affinity at Opioid Receptors(2003)42 cited